GGrantIndex
← Search

FY24-FY33 NIAID-DLA Pharmaceutical Vendor Program

$610,000Y01FY2024AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

The NIAID-DLA IAA enables DAIT/ NIAID to purchase brand name pharmaceutical products (ie: biologics) at a significantly discounted (50-60% cheaper) price for use in NIAID-supported clinical trials.

View original record on NIH RePORTER →
FY24-FY33 NIAID-DLA Pharmaceutical Vendor Program · GrantIndex